The Absorption, Distribution, Excretion, and Biotransformation of the Carcinostatic 1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea in Animals

Cancer Research

Volumn 30, Issue 5, 1970, Pages 1330-1337

  Oliverio, Vincent T ^a   Vietzke, Wesley M ^a   Williams, Mary K ^a   Adamson, Richard H ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBON; NITROSO DERIVATIVE; UREA;

ANIMAL; ARTICLE; BIOTRANSFORMATION; BLOOD; CEREBROSPINAL FLUID; DOG; FECES; FEMALE; HAPLORHINI; LEUKEMIA L 1210; MALE; METABOLISM; MOUSE; PATHOLOGY; PERITONEUM TUMOR; RAT; SKULL TUMOR; THIN LAYER CHROMATOGRAPHY; URINE;

ANIMAL; ANTINEOPLASTIC AGENTS; BIOTRANSFORMATION; CARBON ISOTOPES; CHROMATOGRAPHY, THIN LAYER; DOGS; FECES; FEMALE; HAPLORHINI; LEUKEMIA L1210; MALE; MICE; NITROSO COMPOUNDS; PERITONEAL NEOPLASMS; RATS; SKULL NEOPLASMS; UREA;

EID: 0014790868     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. DeVita, V. T., Carbone, P. P., Owens, A. H., Jr., Gold, G. L., Krant, J. J., and Edmonson, J. Clinical Trials with 1, 3-Bis-(2-chloroethyl)-1-nitrosourea NSC 409962. Cancer Res., 25: 1876–1881, 1965.
2. DeVita, V. T., Denham, C., Davidson, J. D., and Oliverio, V. T. The Physiological Disposition of the Carcinostatic 1, 3-Bis-(2-chloroethyl)-1-nitrosourea (BCNU) in Man and Animals. Clin. Pharmacol. Therap., 8: 566–577, 1967.
3. Dixon, R. L., and Adamson, R. H. Antitumor Activity and Pharmacologic Disposition of Cytosine Arabinoside (NSC 63878). Cancer Chemotherapy Rept., 48: 11–16, 1965.
4. Elliott, T. H., Lee-Yoong, N. Y., and Tao, R. C. C. The Metabolism of Cyclohexylamine in Rabbits. Biochem. J., 109: 11P-12P, 1968.
5. Gale, G. R. Effect of 1, 3-Bis-(2-chloroethyl)-1-nitrosourea on Ehrlich Ascites Tumor Cells. Biochem. Pharmacol., 14: 1707–1712, 1965.
6. Green, S. The Effect of 1, 3-Bis-(2-chloroethyl)-1-nitrosourea on Nicotinamide Adenine Dinucleotide Glycohydrolase of Mouse and Rat Neoplastic and Normal Tissue. Cancer Res., 26: 2481–2484, 1966.
7. Iriarte, P. V., Hananian, J., and Cortner, J. A. Central Nervous System Leukemia and Solid Tumors of Childhood: Treatment with I, 3-Bis-(2-chloroethyl)-1-nitrosourea. Cancer, 19: 1187–1194, 1966.
8. Johnston, T. P., McCaleb, G. S., Opliger, P. S., and Montgomery, J. A. The Synthesis of Potential Anticancer Agents. 36. N-Nitrosoureas. II. Haloalkyl Derivatives. J. Med. Chem., 9: 892–911, 1966.
9. Lessner, H. E. BCNU (1, 3-Bis(β-chloroethyl)-l-nitrosourea. Effects on Advanced Hodgkin's Disease and Other Neoplasia. Cancer, 22/451-456, 1968.
10. Loo, T. L., Dion, R. L., Dixon, R. L., and Rail, D. P. The Antitumor Agent, 1, 3-Bis-(2-chloroethyl)-1-nitrosourea. J. Pharm. Sci., 55: 492–497, 1966.
11. Moertel, C. G., Reitemeier, R. J., Hahn, R. G. Therapy of Advanced Gastrointestinal Cancer with 1, 3-Bis-(2-chloroethyl)-l-nitrosourea (BCNU). Clin. Pharmacol. Therap., 9: 652–656, 1968.
12. Montgomery, J. A., James, R., McCaleb, G. S., and Johnston, T. P. The Modes of Decomposition of 1, 3-Bis-(2-chloroethyl)-1-nitrosourea and Related Compounds. J. Med. Chem., 10: 668–674, 1967.
13. Nies, B. A., Thomas, L. B., and Freireich, E. J. Meningeal Leukemia: A Follow-up Study. Cancer, 18: 546–553, 1965.
14. Oliverio, V. T., and Davidson, J. D. The Physiological Disposition of Dichloromethotrexate-Cl36 in Animals. J. Pharmacol. Exptl. Therap., 137: 76–83, 1962.
15. Rail, D. P., Ben, M., and McCarthy, D. M. 1, 3-bis-β-Chloroethyl-1-nitrosourea (BCNU): Toxicity and Initial Clinical Trial. Proc. Am. Assoc. Cancer Res., 4: 55, 1963.
16. Schabel, F. M., Jr., Johnston, T. P., McCaleb, G. S., Montgomery, J. A., Lester, W. R., and Skipper, H. E. Experimental Evaluation of Potential Anticancer Agents. VIII. Effects of Certain nitrosoureas on Intracerebral L1210 Leukemia. Cancer Res., 23: 725–733, 1963.
17. Steinberg, D. A New Approach to Radioassay of Aqueous Solutions in the Liuqid Scintillation Spectrometer. Anal. Biochem., 1: 23-39, 1960.
18. Sugiura, K. Effect of BCNU on a Spectrum of Tumors. Proc. Am. Assoc. Cancer Res., 6: 62, 1965.
19. Wheeler, G. P. Studies Related to the Mechanism of Action of Cytotoxic Alkylating Agents: A Review. Cancer Res., 22: 651–688, 1962.
20. Wheeler, G. P., and Bowdon, B. J. Effects of 1, 3-Bis-(2-Chloroethyl)-1-nitrosourea upon the Synthesis of Protein and Nucleic Acids in Vivo and in Vitro. Cancer Res., 25: 1770–1778, 1965.
21. Wheeler, G. P., and Bowdon, B. J. Effects of l, 3-Bis-(2-Chloroethyl)-1-nitrosourea and Related Compounds upon the Synthesis of DNA by Cell-free Systems. Cancer Res., 28: 52–59, 1968.